Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best...

A nutritious diet, regular exercise and other components of a healthy lifestyle may reduce the odds of lethal prostate cancer in men with a high genetic risk for it, researchers report. “The excess...

Scientists at Urology Research Laboratory of the Department for BioMedical Research (DBMR), University of Bern and Urology Department of the Inselspital of Bern, have established organoid culture models...

A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins...

Taking a particular type of medication to treat enlarged prostate is associated with a reduced risk of developing Parkinson’s disease, according to a large observational study led by researchers...

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LUCRIN® INJECTION Leuprorelin acetate Consumer Medicine Information (CMI) What is in this leaflet This...

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TOFRANIL® 10 mg and 25 mg tablets Imipramine hydrochloride Consumer Medicine Information What is...

A team of researchers from Google Health, working with others from institutions across the U.S. and Canada has found that a Google AI system was able to outperform general pathologists when validating...

Genetic screening for prostate cancer in GP surgeries could be effective at picking up otherwise undiagnosed cases of the disease, a new pilot study shows. Researchers ‘barcoded’ men for their...

A new type of test that uses complex sugars to detect prostate cancer earlier and with greater accuracy is being developed by researchers at the University of Birmingham. The test works by identifying...